Article Details
Retrieved on: 2021-01-14 22:29:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Incidentally, in July of 2017, Merck and AstraZeneca announced that they would partner to develop cancer therapies using AstraZeneca's PARP ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here